SOPHiA GENETICS Has Expanded An Existing Program In Spain To Increase Access To Local Testing For Homologous Recombination Deficiency Throughout The Country. The Expansion Of The Program Is Supported By AstraZeneca Spain
Author: Benzinga Newsdesk | February 07, 2024 07:53am